• Je něco špatně v tomto záznamu ?

Randomized comparison of atrioventricular node re-entry tachycardia and atrial flutter catheter ablation with and without fluoroscopic guidance: ZeroFluoro study

F. Lehar, N. Szegedi, J. Hejc, J. Jez, F. Soucek, T. Kulik, A. Siruckova, Z. Sallo, KV. Nagy, B. Merkely, L. Geller, Z. Starek

. 2022 ; 24 (10) : 1636-1644. [pub] 2022Oct13

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033078

AIMS: Interventional cardiology procedures may expose patients and staff to considerable radiation doses. We aimed to assess whether exposure to ionizing radiation during catheter ablation of supraventricular tachycardia (SVT) can be completely avoided. METHODS AND RESULTS: In this prospective randomized study, patients with SVT (atrioventricular re-entrant tachycardia n = 94, typical atrial flutter n = 29) were randomly assigned in a 1:1 ratio to catheter ablation with conventional fluoroscopic guidance (CF group) or with the EnSite Precision mapping system [zerofluoro (ZF) group]. Acute procedural parameters, increased stochastic risk of cancer incidence and 6-month follow-up data were assessed. Between May 2019 and August 2020, 123 patients were enrolled. Clinical parameters were comparable. Median procedural time was 60.0 and 58.0 min, median fluoroscopy time and estimated median effective dose were 240 s vs. 0 and 0.38 mSv vs. 0 and arrhythmia recurrence was 5% and 7.9% in the CF and ZF groups, respectively. The acute success rate was 98.4% in both groups. No procedure-related complications were reported. At an average age of 55.5 years and median radiation exposure of 0.38 mSv, the estimate of increased incidence was approximately 1 in 14 084. The estimated mortality rate was 1 per 17 857 exposed persons. CONCLUSIONS: The procedural safety and efficacy of the zero-fluoroscopic approach are similar to those of conventional fluoroscopy-based ablation for atrioventricular nodal re-entrant tachycardia and atrial flutter. Under the assumption of low radiation dose, the excessive lifetime risk of malignancy in the CF group due to electrophysiology procedure is reasonably small, whilst totally reduced in zero fluoroscopy procedures.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033078
003      
CZ-PrNML
005      
20230131151136.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euac049 $2 doi
035    __
$a (PubMed)35979596
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Lehar, Frantisek $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
245    10
$a Randomized comparison of atrioventricular node re-entry tachycardia and atrial flutter catheter ablation with and without fluoroscopic guidance: ZeroFluoro study / $c F. Lehar, N. Szegedi, J. Hejc, J. Jez, F. Soucek, T. Kulik, A. Siruckova, Z. Sallo, KV. Nagy, B. Merkely, L. Geller, Z. Starek
520    9_
$a AIMS: Interventional cardiology procedures may expose patients and staff to considerable radiation doses. We aimed to assess whether exposure to ionizing radiation during catheter ablation of supraventricular tachycardia (SVT) can be completely avoided. METHODS AND RESULTS: In this prospective randomized study, patients with SVT (atrioventricular re-entrant tachycardia n = 94, typical atrial flutter n = 29) were randomly assigned in a 1:1 ratio to catheter ablation with conventional fluoroscopic guidance (CF group) or with the EnSite Precision mapping system [zerofluoro (ZF) group]. Acute procedural parameters, increased stochastic risk of cancer incidence and 6-month follow-up data were assessed. Between May 2019 and August 2020, 123 patients were enrolled. Clinical parameters were comparable. Median procedural time was 60.0 and 58.0 min, median fluoroscopy time and estimated median effective dose were 240 s vs. 0 and 0.38 mSv vs. 0 and arrhythmia recurrence was 5% and 7.9% in the CF and ZF groups, respectively. The acute success rate was 98.4% in both groups. No procedure-related complications were reported. At an average age of 55.5 years and median radiation exposure of 0.38 mSv, the estimate of increased incidence was approximately 1 in 14 084. The estimated mortality rate was 1 per 17 857 exposed persons. CONCLUSIONS: The procedural safety and efficacy of the zero-fluoroscopic approach are similar to those of conventional fluoroscopy-based ablation for atrioventricular nodal re-entrant tachycardia and atrial flutter. Under the assumption of low radiation dose, the excessive lifetime risk of malignancy in the CF group due to electrophysiology procedure is reasonably small, whilst totally reduced in zero fluoroscopy procedures.
650    _2
$a srdeční arytmie $x chirurgie $7 D001145
650    12
$a flutter síní $x diagnostické zobrazování $x chirurgie $7 D001282
650    _2
$a nodus atrioventricularis $7 D001283
650    12
$a katetrizační ablace $x škodlivé účinky $x metody $7 D017115
650    _2
$a fluoroskopie $x metody $7 D005471
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    12
$a atrioventrikulární nodální reentry tachykardie $x diagnostické zobrazování $x chirurgie $7 D013611
650    12
$a supraventrikulární tachykardie $x diagnostické zobrazování $x chirurgie $7 D013617
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Szegedi, Nándor $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
700    1_
$a Hejc, Jakub $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Jez, Jiri $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Soucek, Filip $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Kulik, Tomas $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Siruckova, Anna $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Sallo, Zoltan $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
700    1_
$a Nagy, Klaudia Vivien $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
700    1_
$a Merkely, Bela $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary $1 https://orcid.org/0000000165140723
700    1_
$a Geller, László $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
700    1_
$a Starek, Zdeněk $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic $1 https://orcid.org/0000000295101386
773    0_
$w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 24, č. 10 (2022), s. 1636-1644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35979596 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151132 $b ABA008
999    __
$a ok $b bmc $g 1891692 $s 1184413
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 24 $c 10 $d 1636-1644 $e 2022Oct13 $i 1532-2092 $m Europace $n Europace $x MED00149837
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace